PTPN11 and neoplasm: Investigations regarding the activity of Src Homology 2 domain-containing phosphatase-2 (SHP-2) and the consequential effects on the PI3K/AKT/mTOR signaling cascade in tumor specimens demonstrated a notable suppression of SHP2 allied with an activated state of the aforementioned pathways.